Building healthier connections

between high-potential innovation and investment



























Delivering healthier returns

for the UK’s Life Sciences innovation ecosystem






























Backing breakthroughs for outstanding returns

The UK Life Sciences sector is brimming with potential. To maximise this, bold innovation needs capital, confidence, and the right conditions to grow.

We are here to unlock the most promising opportunities and connect them to the right investors.









About Medicines Discovery Ventures

We are a new early-stage venture fund founded on a promise made by Medicines Discovery Catapult to channel its earnings for reinvestment to build a stronger UK Life Sciences sector.

Learn more




Innovators

We back breakthroughs by building healthier connections between high-potential innovation and investment.

Learn more




Investors

We deliver healthier returns for the UK’s Life Sciences innovation ecosystem by connecting investors to UK ventures that match national demand signals.

Learn more




Speak to us

Speak to us today to see how we can help you.

Speak to us






Testimonials


We are super excited to have Medicines Discovery Ventures as an investor. They bring considerable scientific expertise to our programme to develop new therapeutics for treating obsessive-compulsive disorder (OCD), a common yet poorly treated and often devastating mental illness.



Nick Sireau
CEO, Serenatis Bio

MDV’s involvement has tightened our execution plan, de-risked key experiments, improved funding readiness, and connected us with the right partners, exactly the leverage we need to scale at pace.



Alex Sheppard
CEO, Xenos Bio

ClotProtect is extremely appreciative of the important pre-seed funding from MDV, 02h and angels to validate their approach and is now raising a Seed round to take the development towards selection of a preclinical candidate, IND enabling studies to be ready for first-in-man studies.



Prof. Helen Philippou
CEO & Co-founder, ClotProtect